UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 183

Sortiert nach

GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease

Cell stem cell, 2018-08, Vol.23 (2), p.239-251.e6

2018

Volltextzugriff (PDF)

Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model

Cell reports (Cambridge), 2023-08, Vol.42 (8), p.112841-112841, Article 112841

2023

Volltextzugriff (PDF)

Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases

iScience, 2023-11, Vol.26 (11), p.108037-108037, Article 108037

2023

Volltextzugriff (PDF)

Tyrosinase inhibitors from paper mulberry ( Broussonetia papyrifera)

Food chemistry, 2008-01, Vol.106 (2), p.529-535

2008

Volltextzugriff (PDF)

Small-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes

Cell reports (Cambridge), 2016-07, Vol.16 (3), p.781-792

2016

Volltextzugriff (PDF)

Developing Hypoimmunogenic Human iPSC‐Derived Oligodendrocyte Progenitor Cells as an Off‐The‐Shelf Cell Therapy for Myelin Disorders

Advanced science, 2023-08, Vol.10 (23), p.e2206910-n/a

2023

Volltextzugriff (PDF)

Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells

The Journal of nutritional biochemistry, 2010-06, Vol.21 (6), p.482-489

2010

Volltextzugriff (PDF)

Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene

iScience, 2022-06, Vol.25 (6), p.104391-104391, Article 104391

2022

Volltextzugriff (PDF)

Beneficial Effects of Cinnamon Proanthocyanidins on the Formation of Specific Advanced Glycation Endproducts and Methylglyoxal-Induced Impairment on Glucose Consumption

Journal of agricultural and food chemistry, 2010-06, Vol.58 (11), p.6692-6696

2010

Volltextzugriff (PDF)

Inhibition of mutagenic PhIP formation by epigallocatechin gallate via scavenging of phenylacetaldehyde

Molecular nutrition & food research, 2009-06, Vol.53 (6), p.716-725

2009

Volltextzugriff (PDF)

Modeling neurological diseases using iPSC-derived neural cells: iPSC modeling of neurological diseases

Cell and tissue research, 2018-01, Vol.371 (1), p.143-151

2018

Volltextzugriff (PDF)

In vitro attenuation of acrolein-induced toxicity by phloretin, a phenolic compound from apple

Food chemistry, 2012-12, Vol.135 (3), p.1762-1768

2012

Volltextzugriff (PDF)

A pro-drug of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine

Neuroscience letters, 2010-01, Vol.469 (3), p.360-364

2010

Volltextzugriff (PDF)

Sulfur-containing constituents and one 1H-pyrrole-2-carboxylic acid derivative from pineapple [ Ananas comosus (L.) Merr.] fruit

Phytochemistry (Oxford), 2010-12, Vol.71 (17), p.2046-2051

2010

Volltextzugriff (PDF)

Modeling neurological diseases using iPSC-derived neural cells

Cell and tissue research, 2018-01, Vol.371 (1), p.143-151

2018

Volltextzugriff (PDF)

Oxyresveratrol exerts ATF4- and Grp78-mediated neuroprotection against endoplasmic reticulum stress in experimental Parkinson's disease

Nutritional neuroscience, 2021-03, Vol.24 (3), p.181-196

2021

Volltextzugriff (PDF)

Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis

Nature cancer, 2021-09, Vol.2 (9), p.932

2021

Volltextzugriff (PDF)

Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity

Free radical biology & medicine, 2008-10, Vol.45 (7), p.1019-1026

2008

Volltextzugriff (PDF)

Phosphorylation Stabilized TET1 Acts As an Oncoprotein and Therapeutic Target in B-Cell Acute Lymphoblastic Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.998-1000

2022

Volltextzugriff (PDF)

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia

Science translational medicine, 2023-03, Vol.15 (689), p.eabq8513

2023

Volltextzugriff (PDF)

The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA

Clinical cancer research, 2018-12, Vol.24 (23), p.6053-6065

2018

Volltextzugriff (PDF)

Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs

Advanced science, 2020-12, Vol.7 (23), p.2002155-n/a

2020

Volltextzugriff (PDF)

The anti-cancer activity of a first-in-class small molecule targeting PCNA

Clinical cancer research, 2018-07, Vol.24 (23), p.6053-6065

2018

Volltextzugriff (PDF)

GFAP mutations in astrocytes impair oligodendrocyte progenitor proliferation and myelination in a human iPSC model of Alexander disease

Cell stem cell, 2018-08, Vol.23 (2), p.239-251.e6

2018

Volltextzugriff (PDF)

Stem Cell Therapy: Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs (Adv. Sci. 23/2020)

Advanced science, 2020-12, Vol.7 (23), p.n/a

2020

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(67)
Technology
(57)
Physical Sciences
(45)
Materials Science
(33)
Materials Science, Multidisciplinary
(28)
Chemistry
(26)
Engineering
(22)
Humans
(21)
Science & Technology - Other Topics
(16)
Physics
(14)
Environmental Sciences
(13)
Environmental Sciences & Ecology
(13)
Oncology
(13)
Animals
(12)
Cell Biology
(10)
Biochemistry & Molecular Biology
(9)
Chemistry, Physical
(9)
Computer Science
(8)
Proteins
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease

Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model

Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases

Tyrosinase inhibitors from paper mulberry ( Broussonetia papyrifera)

Small-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes

Developing Hypoimmunogenic Human iPSC‐Derived Oligodendrocyte Progenitor Cells as an Off‐The‐Shelf Cell Therapy for Myelin Disorders

Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells

Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene

Beneficial Effects of Cinnamon Proanthocyanidins on the Formation of Specific Advanced Glycation Endproducts and Methylglyoxal-Induced Impairment on Glucose Consumption

Inhibition of mutagenic PhIP formation by epigallocatechin gallate via scavenging of phenylacetaldehyde

Modeling neurological diseases using iPSC-derived neural cells: iPSC modeling of neurological diseases

In vitro attenuation of acrolein-induced toxicity by phloretin, a phenolic compound from apple

A pro-drug of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine

Sulfur-containing constituents and one 1H-pyrrole-2-carboxylic acid derivative from pineapple [ Ananas comosus (L.) Merr.] fruit

Modeling neurological diseases using iPSC-derived neural cells

Oxyresveratrol exerts ATF4- and Grp78-mediated neuroprotection against endoplasmic reticulum stress in experimental Parkinson's disease

Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis

Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity

Phosphorylation Stabilized TET1 Acts As an Oncoprotein and Therapeutic Target in B-Cell Acute Lymphoblastic Leukemia

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia

The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA

Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs

The anti-cancer activity of a first-in-class small molecule targeting PCNA

GFAP mutations in astrocytes impair oligodendrocyte progenitor proliferation and myelination in a human iPSC model of Alexander disease

Stem Cell Therapy: Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs (Adv. Sci. 23/2020)

Suchergebnisse filtern